CClinicalTrials.gg
Sign In
CompletedNCT05081817Updated Aug 1, 2023

Accuracy Comparison of Two CGMs in Hospitalized Patients

An observational study in Type 1 Diabetes and Type 2 Diabetes, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-01.

Sponsored by University of California, San Diego · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to determine the accuracy of two different continuous blood sugar monitoring systems in hospitalized patients by comparing them standard laboratory blood sugar testing in the hospital.

02

Conditions studied

  • Type 1 Diabetes
  • Type 2 Diabetes

Browse trials for

03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 40 is below the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

ICU patients requiring an insulin drip.

Inclusion criteria

  1. All genders, admitted to UC San Diego Hillcrest Medical Center with an anticipated remaining length of stay of ≥24 hours
  2. Age ≥18 years at the time of consent
  3. Requiring standard of care intravenous insulin infusion therapy at the time of consent with an anticipated duration of intravenous insulin infusion ≥12 hours
  4. Willingness to provide informed consent and follow all study procedures

Exclusion criteria

Exclusion Criteria:

  1. Current bleeding disorder, treatment with anticoagulants, or platelet count below 50,000/mL at enrollment
  2. Lack of appropriate sites for sensor placement (sites must be free of scars, skin irritation, surgical wounds, dressings, etc.)
  3. Planned magnetic resonance imaging (MRI) study within 24 hours of enrollment
  4. Any other condition that, based on Investigator's judgment, would jeopardize patient safety during trial participation or would affect the study outcome
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
40 participants (actual)
Patient registry
No

Groups and cohorts

  • ICU

    ICU patients on insulin drip

06

What researchers measure

Primary outcomes

  1. Difference in glucose measurement

    Difference between glucose as measured by continuous glucose monitor versus laboratory

    Time frame: 5 Days

07

Study locations

1 site
  • UC San Diego Medical Center
    La Jolla, California 92037, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05081817
Lead sponsor
University of California, San Diego
Collaborators
DexCom, Inc.
Responsible party
Schafer Boeder (Assistant Clinical Professor, University of California, San Diego) — Principal investigator
First posted
Oct 18, 2021
Start date
Aug 1, 2019
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Aug 1, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Diabetes Mellitus→

Other studies from this sponsor

University of California, San Diego

Start the discussion